Skip to main content
 

2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015
DateTitle 
02/06/17WAVE Life Sciences to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 6, 2017-- WAVE Life Sciences Ltd. (NASDAQ:WVE), a genetic medicines company focused on developing targeted therapies for patients impacted by rare diseases, today announced that Paul Bolno, M.D., MBA, President and Chief Executive Officer, will be presenting at the following upcoming investor conferences: Leerink Partners Global Healthcare Conference 2017 Wednesday, February 15th at 1:30... 
Printer Friendly Version
01/06/17WAVE Life Sciences 2017 Pipeline Update
Three Lead Neurology Programs to Enter Clinic in 2017 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 6, 2017-- WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company focused on developing targeted therapies for patients impacted by rare diseases, today announced updates to its clinical pipeline for 2017. “2017 will be an important year for WAVE as we transition our two lead candidates in Huntington’s disease and our exon-skipping candida... 
Printer Friendly Version